| ECOVAXXIN® MS EU marketing authorisation granted | 22-Dec-2025 | 07:00 | RNS |
| ECOVAXXIN® MS EU marketing authorisation gr... | 22-Dec-2025 | 07:00 | RNS |
| Exercise of Share Options by Director | 18-Dec-2025 | 07:00 | RNS |
| Holding(s) in Company | 09-Dec-2025 | 17:57 | RNS |
| Director/PDMR Shareholding | 04-Dec-2025 | 14:10 | RNS |
| Results for the six months ended 30 September 2025 | 01-Dec-2025 | 07:00 | RNS |
| Replacement: Notice of Results | 20-Nov-2025 | 09:47 | RNS |
| Notice of Results | 20-Nov-2025 | 07:00 | RNS |
| EMA Positive Opinion Received for ECOVAXXIN®... | 10-Nov-2025 | 07:00 | RNS |
| Result of AGM | 25-Sep-2025 | 15:15 | RNS |
| AGM Trading Update and Notice of Interim Results | 25-Sep-2025 | 07:00 | RNS |
| Appointment of Joint Broker | 01-Sep-2025 | 07:00 | RNS |
| Share Awards to Executive Directors | 29-Aug-2025 | 07:00 | RNS |
| Posting of Annual Report and Notice of AGM | 28-Aug-2025 | 07:48 | RNS |
| Result of General Meeting | 21-Aug-2025 | 12:29 | RNS |
| Currency | UK Pounds |
| Share Price | 101.05p |
| Change Today | -3.45p |
| % Change | -3.30 % |
| 52 Week High | 110.00p |
| 52 Week Low | 51.50p |
| Volume | 2,517 |
| Shares Issued | 67.76m |
| Market Cap | £68.47m |
| Beta | 0.09 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 23-Sep-21 | 26-Sep-19 |
| Paid | 22-Oct-21 | 16-Oct-19 |
| Amount | 1.00p | 7.04p |
| CFO | Christopher Wilks |
| CEO | David Hallas |
You are here: research